| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoblastoma Protein | 80 | 2023 | 704 | 11.870 |
Why?
|
| E2F Transcription Factors | 49 | 2023 | 277 | 5.280 |
Why?
|
| Drosophila Proteins | 38 | 2021 | 1702 | 5.020 |
Why?
|
| Drosophila melanogaster | 20 | 2014 | 1708 | 2.660 |
Why?
|
| E2F1 Transcription Factor | 20 | 2022 | 190 | 2.510 |
Why?
|
| Transcription Factors | 57 | 2023 | 12207 | 2.470 |
Why?
|
| Cell Cycle Proteins | 46 | 2023 | 3461 | 2.430 |
Why?
|
| Cell Cycle | 37 | 2023 | 2967 | 1.800 |
Why?
|
| Drosophila | 20 | 2021 | 1491 | 1.650 |
Why?
|
| DNA-Binding Proteins | 49 | 2017 | 9647 | 1.600 |
Why?
|
| Chromatin | 17 | 2023 | 2934 | 1.330 |
Why?
|
| Trans-Activators | 13 | 2017 | 2924 | 1.280 |
Why?
|
| Chromosomal Instability | 4 | 2014 | 184 | 1.220 |
Why?
|
| E2F2 Transcription Factor | 10 | 2014 | 38 | 1.150 |
Why?
|
| Carrier Proteins | 29 | 2004 | 5021 | 1.110 |
Why?
|
| Oncogene Proteins, Viral | 15 | 2006 | 362 | 1.050 |
Why?
|
| Histone Demethylases | 4 | 2015 | 321 | 1.030 |
Why?
|
| Fat Body | 3 | 2021 | 32 | 0.940 |
Why?
|
| Oxidoreductases, N-Demethylating | 4 | 2015 | 115 | 0.880 |
Why?
|
| RNA-Binding Proteins | 4 | 2016 | 1903 | 0.840 |
Why?
|
| Retinoblastoma | 8 | 2021 | 318 | 0.830 |
Why?
|
| S Phase | 16 | 2014 | 423 | 0.800 |
Why?
|
| Gene Expression Regulation | 20 | 2015 | 12075 | 0.790 |
Why?
|
| Histones | 10 | 2014 | 2600 | 0.790 |
Why?
|
| Nuclear Proteins | 25 | 2014 | 5853 | 0.770 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2021 | 8426 | 0.760 |
Why?
|
| Retinoblastoma Binding Proteins | 2 | 2021 | 97 | 0.730 |
Why?
|
| Cyclin-Dependent Kinase 4 | 7 | 2019 | 535 | 0.690 |
Why?
|
| Cyclin-Dependent Kinase 6 | 3 | 2019 | 322 | 0.680 |
Why?
|
| Repressor Proteins | 14 | 2011 | 3023 | 0.670 |
Why?
|
| Chromosomal Proteins, Non-Histone | 5 | 2014 | 736 | 0.660 |
Why?
|
| Chromosome Structures | 1 | 2018 | 14 | 0.660 |
Why?
|
| Gene Expression Regulation, Developmental | 12 | 2021 | 3617 | 0.630 |
Why?
|
| Adenosine Triphosphatases | 4 | 2012 | 839 | 0.620 |
Why?
|
| Transcription, Genetic | 18 | 2021 | 7723 | 0.620 |
Why?
|
| Cyclin-Dependent Kinases | 8 | 2008 | 671 | 0.610 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 25 | 2000 | 142 | 0.610 |
Why?
|
| Apoptosis | 19 | 2019 | 9728 | 0.600 |
Why?
|
| Histone Code | 1 | 2018 | 163 | 0.600 |
Why?
|
| Oxidative Phosphorylation | 2 | 2019 | 480 | 0.590 |
Why?
|
| Animals | 102 | 2023 | 168788 | 0.590 |
Why?
|
| Cell Proliferation | 12 | 2019 | 10480 | 0.580 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2014 | 390 | 0.580 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2014 | 2848 | 0.550 |
Why?
|
| Mitosis | 8 | 2013 | 1208 | 0.550 |
Why?
|
| Cell Division | 15 | 2023 | 4567 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2016 | 286 | 0.540 |
Why?
|
| DNA Replication | 13 | 2022 | 1399 | 0.530 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2014 | 704 | 0.520 |
Why?
|
| Centromere | 3 | 2014 | 220 | 0.520 |
Why?
|
| Small Cell Lung Carcinoma | 4 | 2022 | 388 | 0.510 |
Why?
|
| Methylation | 9 | 2014 | 1108 | 0.510 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2015 | 436 | 0.500 |
Why?
|
| Cell Nucleus | 4 | 2022 | 2969 | 0.500 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2016 | 799 | 0.490 |
Why?
|
| DNA Damage | 11 | 2022 | 2432 | 0.480 |
Why?
|
| Tumor Suppressor Protein p53 | 9 | 2013 | 2948 | 0.470 |
Why?
|
| Transcription Factor DP1 | 20 | 2003 | 141 | 0.450 |
Why?
|
| Genes, Retinoblastoma | 9 | 2012 | 136 | 0.450 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 508 | 0.450 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2013 | 671 | 0.450 |
Why?
|
| G1 Phase | 11 | 2009 | 415 | 0.450 |
Why?
|
| Signal Transduction | 13 | 2019 | 23404 | 0.440 |
Why?
|
| Cell Line, Tumor | 18 | 2022 | 16687 | 0.440 |
Why?
|
| Protein Binding | 20 | 2022 | 9392 | 0.420 |
Why?
|
| Metabolism | 1 | 2013 | 193 | 0.410 |
Why?
|
| Eye | 9 | 2011 | 729 | 0.410 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2021 | 1860 | 0.400 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2016 | 2942 | 0.400 |
Why?
|
| Suppression, Genetic | 5 | 2006 | 196 | 0.400 |
Why?
|
| RNA, Small Interfering | 5 | 2015 | 3505 | 0.390 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2015 | 987 | 0.390 |
Why?
|
| Proteins | 10 | 2001 | 6101 | 0.380 |
Why?
|
| Chromatin Immunoprecipitation | 6 | 2023 | 893 | 0.380 |
Why?
|
| Phosphoproteins | 10 | 2001 | 2440 | 0.370 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2014 | 1086 | 0.370 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2023 | 5169 | 0.370 |
Why?
|
| Phenotype | 16 | 2022 | 16365 | 0.370 |
Why?
|
| RNA Interference | 9 | 2015 | 2890 | 0.360 |
Why?
|
| Neoplasms | 11 | 2018 | 21672 | 0.360 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2012 | 362 | 0.350 |
Why?
|
| Glutamine | 1 | 2013 | 578 | 0.350 |
Why?
|
| Mutation | 25 | 2023 | 29784 | 0.350 |
Why?
|
| Genomic Instability | 6 | 2023 | 695 | 0.350 |
Why?
|
| Intestine, Small | 1 | 2015 | 1241 | 0.330 |
Why?
|
| Animals, Genetically Modified | 8 | 2014 | 1549 | 0.320 |
Why?
|
| Papillomaviridae | 6 | 2005 | 1119 | 0.320 |
Why?
|
| E2F7 Transcription Factor | 1 | 2008 | 2 | 0.320 |
Why?
|
| Phosphorylation | 10 | 2019 | 8437 | 0.310 |
Why?
|
| Retinoblastoma-Like Protein p107 | 11 | 2001 | 74 | 0.290 |
Why?
|
| Blotting, Western | 8 | 2016 | 5180 | 0.290 |
Why?
|
| Larva | 4 | 2013 | 519 | 0.290 |
Why?
|
| Anaphase | 1 | 2006 | 120 | 0.290 |
Why?
|
| Chromosome Segregation | 3 | 2014 | 236 | 0.280 |
Why?
|
| Histone Deacetylases | 5 | 2022 | 729 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2001 | 4553 | 0.270 |
Why?
|
| Embryonic Structures | 1 | 2005 | 9 | 0.270 |
Why?
|
| Cell Survival | 7 | 2017 | 5881 | 0.270 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2006 | 168 | 0.270 |
Why?
|
| Gene Silencing | 3 | 2016 | 1538 | 0.260 |
Why?
|
| Multiprotein Complexes | 2 | 2010 | 1119 | 0.260 |
Why?
|
| Mitochondria | 3 | 2015 | 3520 | 0.250 |
Why?
|
| Embryonic Development | 2 | 2008 | 711 | 0.250 |
Why?
|
| Molecular Sequence Data | 27 | 2006 | 18116 | 0.240 |
Why?
|
| Binding Sites | 12 | 2014 | 6116 | 0.240 |
Why?
|
| Epithelial Cells | 2 | 2016 | 3690 | 0.240 |
Why?
|
| Cyclins | 5 | 2000 | 603 | 0.240 |
Why?
|
| Adenovirus E1A Proteins | 4 | 2005 | 76 | 0.230 |
Why?
|
| Antigens, Polyomavirus Transforming | 5 | 2009 | 258 | 0.230 |
Why?
|
| Cells, Cultured | 16 | 2015 | 19227 | 0.230 |
Why?
|
| Amino Acid Sequence | 22 | 2006 | 13817 | 0.220 |
Why?
|
| beta Catenin | 1 | 2008 | 1059 | 0.220 |
Why?
|
| Cell Line | 12 | 2022 | 15999 | 0.220 |
Why?
|
| DNA | 10 | 2022 | 7303 | 0.220 |
Why?
|
| Molecular Targeted Therapy | 4 | 2023 | 2727 | 0.220 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2003 | 113 | 0.220 |
Why?
|
| Gene Deletion | 5 | 2014 | 2751 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 8 | 2022 | 5867 | 0.210 |
Why?
|
| Insect Proteins | 2 | 2000 | 258 | 0.210 |
Why?
|
| Cell Transformation, Viral | 5 | 2006 | 565 | 0.210 |
Why?
|
| Receptors, Notch | 3 | 2011 | 739 | 0.210 |
Why?
|
| Humans | 84 | 2023 | 744220 | 0.210 |
Why?
|
| Cyclin E | 5 | 2006 | 172 | 0.210 |
Why?
|
| Alleles | 7 | 2012 | 6938 | 0.210 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2022 | 102 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2019 | 3557 | 0.200 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 315 | 0.200 |
Why?
|
| Cytidine Deaminase | 1 | 2023 | 252 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2016 | 3921 | 0.200 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 1157 | 0.190 |
Why?
|
| Genes, Insect | 2 | 1999 | 268 | 0.190 |
Why?
|
| Mice | 37 | 2021 | 81178 | 0.190 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2013 | 182 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 3 | 2019 | 5257 | 0.190 |
Why?
|
| Autophagy | 2 | 2022 | 1300 | 0.190 |
Why?
|
| Transfection | 8 | 2016 | 5892 | 0.190 |
Why?
|
| In Situ Hybridization | 4 | 2012 | 1950 | 0.190 |
Why?
|
| Retinoblastoma-Like Protein p130 | 5 | 2001 | 76 | 0.180 |
Why?
|
| Models, Biological | 7 | 2013 | 9582 | 0.180 |
Why?
|
| Nucleotides | 2 | 2013 | 464 | 0.180 |
Why?
|
| HeLa Cells | 7 | 2015 | 3129 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2012 | 2958 | 0.180 |
Why?
|
| Arabidopsis Proteins | 1 | 2002 | 262 | 0.180 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 742 | 0.180 |
Why?
|
| Lung Neoplasms | 6 | 2023 | 13096 | 0.180 |
Why?
|
| Retinal Neoplasms | 1 | 2021 | 144 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7879 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 10 | 2019 | 6313 | 0.170 |
Why?
|
| Aspergillus nidulans | 2 | 1989 | 10 | 0.170 |
Why?
|
| Sirtuin 1 | 2 | 2011 | 245 | 0.170 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2005 | 964 | 0.170 |
Why?
|
| Polyomavirus | 2 | 1990 | 248 | 0.170 |
Why?
|
| DNA Repair | 4 | 2018 | 2046 | 0.160 |
Why?
|
| Cullin Proteins | 2 | 2010 | 180 | 0.160 |
Why?
|
| DNA Methylation | 2 | 2016 | 4289 | 0.160 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2016 | 1097 | 0.160 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2019 | 167 | 0.160 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 113 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4752 | 0.160 |
Why?
|
| Cyclin D3 | 1 | 2017 | 55 | 0.150 |
Why?
|
| Multigene Family | 2 | 2012 | 1102 | 0.150 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2021 | 332 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2019 | 1143 | 0.150 |
Why?
|
| Proliferating Cell Nuclear Antigen | 5 | 2010 | 285 | 0.150 |
Why?
|
| Genome | 3 | 2023 | 1808 | 0.150 |
Why?
|
| Oncogenes | 3 | 1999 | 1265 | 0.140 |
Why?
|
| Stress, Physiological | 2 | 2015 | 1404 | 0.140 |
Why?
|
| Proteomics | 3 | 2021 | 3637 | 0.140 |
Why?
|
| Heterochromatin | 2 | 2011 | 296 | 0.140 |
Why?
|
| Serine | 2 | 2017 | 828 | 0.140 |
Why?
|
| GTP-Binding Proteins | 1 | 2000 | 970 | 0.140 |
Why?
|
| Blotting, Northern | 4 | 2005 | 1581 | 0.140 |
Why?
|
| Polyadenylation | 1 | 2016 | 117 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2012 | 3747 | 0.130 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 3646 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2010 | 635 | 0.130 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 20817 | 0.130 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 186 | 0.130 |
Why?
|
| Fasting | 2 | 2013 | 1591 | 0.130 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 890 | 0.130 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2014 | 25 | 0.130 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2014 | 58 | 0.120 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2015 | 137 | 0.120 |
Why?
|
| Transcriptional Activation | 9 | 2002 | 1782 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 104 | 0.120 |
Why?
|
| Lipogenesis | 1 | 2015 | 212 | 0.120 |
Why?
|
| MyoD Protein | 1 | 2014 | 151 | 0.120 |
Why?
|
| Papillomavirus E7 Proteins | 5 | 2006 | 123 | 0.120 |
Why?
|
| Adenovirus Early Proteins | 7 | 1992 | 57 | 0.120 |
Why?
|
| Neuropeptides | 2 | 2012 | 942 | 0.110 |
Why?
|
| Cadherins | 2 | 2009 | 907 | 0.110 |
Why?
|
| Origin Recognition Complex | 1 | 2012 | 19 | 0.110 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 479 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 1999 | 2839 | 0.110 |
Why?
|
| Testis | 1 | 1996 | 800 | 0.110 |
Why?
|
| Ubiquitin | 2 | 2008 | 852 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 809 | 0.110 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 232 | 0.110 |
Why?
|
| HCT116 Cells | 1 | 2013 | 408 | 0.100 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2011 | 39 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 2938 | 0.100 |
Why?
|
| RNA, Fungal | 2 | 1989 | 164 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1655 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 1114 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2010 | 1990 | 0.100 |
Why?
|
| Mice, Knockout | 10 | 2008 | 14556 | 0.100 |
Why?
|
| Eye Neoplasms | 3 | 1990 | 313 | 0.100 |
Why?
|
| Adenoviruses, Human | 1 | 1992 | 257 | 0.100 |
Why?
|
| Lysine | 2 | 2013 | 1008 | 0.090 |
Why?
|
| Cell Differentiation | 7 | 2006 | 11478 | 0.090 |
Why?
|
| Eye Proteins | 1 | 2014 | 646 | 0.090 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2011 | 177 | 0.090 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2010 | 52 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3598 | 0.090 |
Why?
|
| Glutathione | 1 | 2013 | 588 | 0.090 |
Why?
|
| Lysosomes | 1 | 2015 | 893 | 0.090 |
Why?
|
| Drug Synergism | 1 | 2014 | 1791 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 513 | 0.090 |
Why?
|
| Base Sequence | 13 | 1996 | 12801 | 0.090 |
Why?
|
| Glioma | 2 | 2002 | 3401 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2001 | 1434 | 0.090 |
Why?
|
| DNA Tumor Viruses | 1 | 1989 | 4 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 2 | 2011 | 3614 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 3846 | 0.090 |
Why?
|
| JC Virus | 1 | 1989 | 85 | 0.090 |
Why?
|
| Genomics | 2 | 2018 | 5722 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 996 | 0.080 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1989 | 154 | 0.080 |
Why?
|
| Embryo, Nonmammalian | 3 | 2005 | 894 | 0.080 |
Why?
|
| Simian virus 40 | 1 | 1989 | 295 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2505 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2008 | 52 | 0.080 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 684 | 0.080 |
Why?
|
| Neurons | 4 | 2001 | 9335 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11493 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2013 | 1251 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2108 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2002 | 1724 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2019 | 1634 | 0.080 |
Why?
|
| Phthalazines | 2 | 2022 | 363 | 0.080 |
Why?
|
| Glycolysis | 3 | 2017 | 826 | 0.080 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 219 | 0.080 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 140 | 0.080 |
Why?
|
| Genes, Reporter | 2 | 2005 | 1547 | 0.080 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2187 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2008 | 188 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1341 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2011 | 1682 | 0.080 |
Why?
|
| Mice, Mutant Strains | 6 | 2006 | 1866 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 1996 | 2050 | 0.080 |
Why?
|
| Research | 1 | 2016 | 1999 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2012 | 2455 | 0.080 |
Why?
|
| Colon | 1 | 2015 | 1772 | 0.070 |
Why?
|
| Genes, myc | 1 | 2008 | 399 | 0.070 |
Why?
|
| Aneuploidy | 2 | 2012 | 530 | 0.070 |
Why?
|
| Genes, Dominant | 2 | 2000 | 880 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2012 | 2007 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 2002 | 2256 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2649 | 0.070 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2006 | 90 | 0.070 |
Why?
|
| Genetic Complementation Test | 2 | 1999 | 562 | 0.070 |
Why?
|
| Female | 20 | 2019 | 380197 | 0.070 |
Why?
|
| Models, Genetic | 3 | 2005 | 3494 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2002 | 3481 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 430 | 0.070 |
Why?
|
| Cell Death | 3 | 2012 | 1708 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2012 | 1538 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 18027 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 2916 | 0.070 |
Why?
|
| Crosses, Genetic | 2 | 2005 | 791 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2010 | 3001 | 0.070 |
Why?
|
| Fibroblasts | 5 | 2013 | 4156 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2006 | 323 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3085 | 0.070 |
Why?
|
| RNA, Messenger | 6 | 2015 | 13036 | 0.070 |
Why?
|
| Enzyme Inhibitors | 4 | 2019 | 3800 | 0.070 |
Why?
|
| Neoplasm Proteins | 3 | 2002 | 3703 | 0.070 |
Why?
|
| Precipitin Tests | 3 | 2003 | 829 | 0.060 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2004 | 3 | 0.060 |
Why?
|
| Retinoblastoma-Binding Protein 4 | 1 | 2004 | 12 | 0.060 |
Why?
|
| Purines | 2 | 2019 | 594 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1990 | 1086 | 0.060 |
Why?
|
| Aminopyridines | 2 | 2019 | 542 | 0.060 |
Why?
|
| Human papillomavirus 16 | 1 | 2006 | 262 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2012 | 1219 | 0.060 |
Why?
|
| Homozygote | 3 | 2005 | 1786 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2008 | 721 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2011 | 5974 | 0.060 |
Why?
|
| Binding, Competitive | 4 | 1992 | 1159 | 0.060 |
Why?
|
| Conserved Sequence | 2 | 2000 | 1202 | 0.060 |
Why?
|
| Transgenes | 2 | 2005 | 1009 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 1451 | 0.060 |
Why?
|
| RNA Splicing | 1 | 1988 | 907 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2004 | 234 | 0.060 |
Why?
|
| Organisms, Genetically Modified | 1 | 2002 | 64 | 0.050 |
Why?
|
| Enzyme Activation | 3 | 2009 | 3701 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2003 | 191 | 0.050 |
Why?
|
| Amino Acid Motifs | 2 | 2002 | 936 | 0.050 |
Why?
|
| Growth Inhibitors | 2 | 1994 | 385 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6172 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1676 | 0.050 |
Why?
|
| Tyrphostins | 1 | 2002 | 67 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 336 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2009 | 1639 | 0.050 |
Why?
|
| Chromosomes | 1 | 2005 | 596 | 0.050 |
Why?
|
| Cyclin D1 | 2 | 2001 | 462 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2001 | 90 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2002 | 190 | 0.050 |
Why?
|
| Trophoblasts | 1 | 2003 | 215 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2009 | 2263 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2002 | 205 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2001 | 1888 | 0.050 |
Why?
|
| Glucose | 1 | 2013 | 4396 | 0.050 |
Why?
|
| Trehalose | 1 | 2021 | 88 | 0.050 |
Why?
|
| Fetal Death | 1 | 2003 | 447 | 0.050 |
Why?
|
| Luciferases | 1 | 2003 | 733 | 0.050 |
Why?
|
| Gene Expression | 4 | 1998 | 7799 | 0.050 |
Why?
|
| Ovary | 1 | 2005 | 981 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2022 | 317 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4841 | 0.050 |
Why?
|
| Genome, Human | 1 | 2014 | 4420 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2700 | 0.050 |
Why?
|
| DCMP Deaminase | 1 | 2019 | 7 | 0.050 |
Why?
|
| Cyclin D | 1 | 2000 | 71 | 0.050 |
Why?
|
| Caspases | 2 | 2001 | 928 | 0.050 |
Why?
|
| Piperazines | 2 | 2022 | 2491 | 0.050 |
Why?
|
| Carbohydrate Metabolism | 1 | 2021 | 264 | 0.050 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2002 | 215 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2002 | 364 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2008 | 2504 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 431 | 0.040 |
Why?
|
| Genes, cdc | 1 | 1999 | 116 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2004 | 789 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2000 | 384 | 0.040 |
Why?
|
| Potassium Channels | 1 | 2002 | 563 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11368 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2023 | 594 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 11074 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 2915 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1999 | 191 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2015 | 443 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 323 | 0.040 |
Why?
|
| Protein Stability | 2 | 2010 | 557 | 0.040 |
Why?
|
| E2F3 Transcription Factor | 2 | 1994 | 40 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2006 | 2019 | 0.040 |
Why?
|
| Yeasts | 1 | 1999 | 285 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 1999 | 210 | 0.040 |
Why?
|
| Phosphofructokinase-1 | 1 | 2017 | 51 | 0.040 |
Why?
|
| Dimerization | 1 | 1999 | 893 | 0.040 |
Why?
|
| Gene Targeting | 4 | 2006 | 880 | 0.040 |
Why?
|
| Reactive Nitrogen Species | 1 | 2017 | 35 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 1999 | 388 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 1997 | 158 | 0.040 |
Why?
|
| Gamma Rays | 1 | 1998 | 320 | 0.040 |
Why?
|
| Male | 10 | 2021 | 350027 | 0.040 |
Why?
|
| Nervous System | 1 | 2000 | 554 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2017 | 124 | 0.040 |
Why?
|
| Vinblastine | 1 | 1998 | 490 | 0.040 |
Why?
|
| Retinal Dysplasia | 1 | 1996 | 15 | 0.040 |
Why?
|
| Lung | 1 | 2015 | 9852 | 0.040 |
Why?
|
| Exocrine Glands | 1 | 1996 | 50 | 0.040 |
Why?
|
| Sarcoma, Experimental | 1 | 1996 | 128 | 0.030 |
Why?
|
| Vincristine | 1 | 1998 | 1036 | 0.030 |
Why?
|
| Telomerase | 1 | 2001 | 729 | 0.030 |
Why?
|
| Muscles | 1 | 2021 | 1622 | 0.030 |
Why?
|
| Cloning, Molecular | 4 | 1994 | 4321 | 0.030 |
Why?
|
| Transaminases | 1 | 2016 | 199 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 8 | 2015 | 21824 | 0.030 |
Why?
|
| Retroelements | 1 | 2016 | 164 | 0.030 |
Why?
|
| Pyruvate Kinase | 1 | 2017 | 189 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 5529 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 2001 | 1701 | 0.030 |
Why?
|
| S-Adenosylmethionine | 1 | 2016 | 212 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 914 | 0.030 |
Why?
|
| Quinazolines | 1 | 2002 | 1356 | 0.030 |
Why?
|
| Phylogeny | 1 | 2002 | 2803 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13668 | 0.030 |
Why?
|
| Pancreatic Ducts | 1 | 2016 | 328 | 0.030 |
Why?
|
| Chimera | 1 | 1996 | 485 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 2006 | 1587 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1998 | 623 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1992 | 427 | 0.030 |
Why?
|
| Response Elements | 1 | 2015 | 311 | 0.030 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2015 | 251 | 0.030 |
Why?
|
| Time Factors | 2 | 2012 | 40063 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1877 | 0.030 |
Why?
|
| Glycine | 1 | 2016 | 671 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 608 | 0.030 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 407 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 315 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 3689 | 0.030 |
Why?
|
| Fetus | 1 | 2000 | 1880 | 0.030 |
Why?
|
| Metabolomics | 1 | 2021 | 1483 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 1992 | 263 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1996 | 526 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2716 | 0.030 |
Why?
|
| Immunosorbent Techniques | 1 | 1992 | 184 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1996 | 749 | 0.030 |
Why?
|
| Cell Nucleolus | 2 | 2004 | 166 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1993 | 841 | 0.030 |
Why?
|
| Prognosis | 3 | 2019 | 29050 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1526 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2001 | 2422 | 0.020 |
Why?
|
| Caenorhabditis elegans | 2 | 2010 | 1420 | 0.020 |
Why?
|
| Atrophy | 1 | 1996 | 1582 | 0.020 |
Why?
|
| Plasmids | 2 | 1994 | 2307 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2186 | 0.020 |
Why?
|
| Viral Proteins | 2 | 1996 | 1900 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 2085 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14726 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 1586 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 658 | 0.020 |
Why?
|
| Extremities | 1 | 1996 | 865 | 0.020 |
Why?
|
| Naphthols | 1 | 2010 | 45 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2006 | 4033 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 2 | 2001 | 137 | 0.020 |
Why?
|
| Receptors, Invertebrate Peptide | 1 | 2009 | 11 | 0.020 |
Why?
|
| Mice, Transgenic | 4 | 2006 | 9735 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2019 | 10250 | 0.020 |
Why?
|
| Longevity | 1 | 1998 | 1069 | 0.020 |
Why?
|
| DNA Viruses | 1 | 1990 | 36 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1996 | 931 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2001 | 295 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2078 | 0.020 |
Why?
|
| Haplorhini | 1 | 1990 | 552 | 0.020 |
Why?
|
| Amino Acids | 1 | 2015 | 1734 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1692 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2002 | 8860 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 1677 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1996 | 1380 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 905 | 0.020 |
Why?
|
| Xenopus | 1 | 2010 | 712 | 0.020 |
Why?
|
| Papio | 1 | 1990 | 656 | 0.020 |
Why?
|
| Caspase 3 | 2 | 2001 | 759 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 1989 | 280 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 416 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1989 | 455 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 1989 | 898 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2019 | 2940 | 0.020 |
Why?
|
| Sirtuins | 1 | 2010 | 323 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1085 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2000 | 3585 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 1988 | 247 | 0.020 |
Why?
|
| Retroviridae | 1 | 1990 | 914 | 0.020 |
Why?
|
| Lymphoma | 1 | 1996 | 1873 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3523 | 0.020 |
Why?
|
| Homeostasis | 2 | 2015 | 3339 | 0.020 |
Why?
|
| Epithelium | 1 | 2011 | 1680 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 4188 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 6757 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 1011 | 0.020 |
Why?
|
| Rabbits | 1 | 1992 | 4892 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1992 | 2226 | 0.020 |
Why?
|
| Protein Biosynthesis | 2 | 1990 | 2126 | 0.020 |
Why?
|
| Benzamides | 1 | 2010 | 1378 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 365 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4201 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2895 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2012 | 4803 | 0.010 |
Why?
|
| DNA Polymerase III | 1 | 2004 | 55 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2000 | 5709 | 0.010 |
Why?
|
| Virus Replication | 1 | 1992 | 2534 | 0.010 |
Why?
|
| Liver | 2 | 2015 | 7472 | 0.010 |
Why?
|
| Peptides | 2 | 1992 | 4407 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13280 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2237 | 0.010 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2006 | 387 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2003 | 242 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2005 | 1184 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 6352 | 0.010 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2001 | 20 | 0.010 |
Why?
|
| Replication Protein C | 1 | 2001 | 19 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2001 | 128 | 0.010 |
Why?
|
| Hydro-Lyases | 1 | 2001 | 94 | 0.010 |
Why?
|
| Lamins | 1 | 2000 | 36 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2911 | 0.010 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2005 | 484 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9230 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 438 | 0.010 |
Why?
|
| Middle Aged | 3 | 2019 | 213367 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2000 | 554 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2001 | 298 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 1999 | 36 | 0.010 |
Why?
|
| Coumarins | 1 | 2000 | 119 | 0.010 |
Why?
|
| Lamin Type A | 1 | 2000 | 190 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 1854 | 0.010 |
Why?
|
| Estrogens | 1 | 2006 | 1565 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1999 | 143 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2000 | 1101 | 0.010 |
Why?
|
| Glutathione Transferase | 2 | 1991 | 595 | 0.010 |
Why?
|
| Lipids | 1 | 2010 | 3305 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 1161 | 0.010 |
Why?
|
| Brain | 2 | 2011 | 26413 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2009 | 4026 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 25043 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 1999 | 220 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 964 | 0.010 |
Why?
|
| Camptothecin | 1 | 2001 | 576 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2001 | 912 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 163253 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 1267 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 9275 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 1060 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1998 | 755 | 0.010 |
Why?
|
| Rats | 2 | 1991 | 24273 | 0.010 |
Why?
|
| Stem Cells | 2 | 2001 | 3567 | 0.010 |
Why?
|
| Kinetics | 2 | 1996 | 6474 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1999 | 550 | 0.010 |
Why?
|
| DNA Helicases | 1 | 2001 | 861 | 0.010 |
Why?
|
| Body Weight | 2 | 1996 | 4666 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 1827 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20123 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1996 | 6612 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2000 | 1178 | 0.010 |
Why?
|
| Growth Plate | 1 | 1996 | 274 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57768 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1996 | 404 | 0.010 |
Why?
|
| Adenovirus E2 Proteins | 1 | 1993 | 8 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 1993 | 31 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1999 | 2726 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 1456 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 1994 | 117 | 0.010 |
Why?
|
| Species Specificity | 1 | 1998 | 2480 | 0.010 |
Why?
|
| Germinal Center | 1 | 1996 | 377 | 0.010 |
Why?
|
| Bone Development | 1 | 1996 | 483 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63119 | 0.010 |
Why?
|
| Cartilage | 1 | 1996 | 818 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1991 | 3772 | 0.010 |
Why?
|
| Heterozygote | 1 | 1998 | 2805 | 0.010 |
Why?
|
| Protein Multimerization | 1 | 1996 | 971 | 0.010 |
Why?
|
| Mammals | 1 | 1996 | 1144 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1996 | 881 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 2752 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1989 | 476 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1998 | 1346 | 0.010 |
Why?
|
| DNA Primers | 1 | 1993 | 2892 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 214035 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1996 | 1357 | 0.010 |
Why?
|
| Actins | 1 | 1996 | 2121 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 1998 | 2732 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 4455 | 0.000 |
Why?
|
| Keratinocytes | 1 | 1989 | 798 | 0.000 |
Why?
|
| Adenoviridae | 1 | 1990 | 1099 | 0.000 |
Why?
|
| Retina | 1 | 1996 | 2616 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 1401 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1993 | 4742 | 0.000 |
Why?
|
| Thyroid Neoplasms | 1 | 1998 | 2281 | 0.000 |
Why?
|
| Bone Neoplasms | 1 | 1996 | 2525 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4935 | 0.000 |
Why?
|
| Pregnancy | 1 | 1999 | 29142 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2002 | 53280 | 0.000 |
Why?
|